C annabis, or marijuana, is one of th e most comm only used illicit drugs, but the debate rages in several countries r egar ding whether or not it should be lega lized. With marijuan a's legalization come serious .:onsiderations for the medica! community, such as \Vhat are the consequences of long-term use?
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'..vhat are the medical and psychologi.:al risks? and Who are the people most vulnerable to its negative effects? For example, are those with a predisposition for developing schizophrenia likely to have an earlier age at onset if they use marijuana?
Recent research I has revealed a connection between cannabis use and schizophrenia outcomes later in life, especially in adolescent cannabis user s.
Schizophrenia, which affects about 2.4 million Americans, is a chronic brain disorder that causes subst;mlial disabiJity2 and has a high worldwide cost and burden of care.3 Although no cure is available, tools can help clin icians accu rately diagnose and treat the condition, and possible genetic markers may outline future treatment targets. Because the typical age at on set for schizo phrenia is between 18 and 25 year s, pediatricians as well as family practitioners and psychiatrists who see young patients should screen them for marijuana use and educ;lte patients and parents on the associated risks.
A. Eden Evins, MD, M PH, assembled an international group of experts to dis cuss the effect of marijuana on the risk for schizophrenia. The group addressed risk factors of schizophrenia, consequences of cannabis use, the potency of different types of cannabis and its effects, the effects of concurrent alcohol and tobacco use with cannabis, and the implications of legalizing marijuana.
WHO NEEDS TO KNOW ABOUT THE RISKS ASSOCIATED WITH MARIJUANA USE?
Dr Kane: Pinpointing the audience for our concerns about cannabis is a challenge. Pediatricians and child psychiatrists especially need to know about the risks for de\'eloping schizophrenia that are associated with cannabis lise, but education also should be shared with the pu blic, families with preadolescent children, school counsciors, and others who interact with youths. The intention here is not to scare people, but rather, to give them some realistic guidance. The key is to share a balanced message by saying that some people have a substantial increase in risk for psychosis following m arijuana use.
Dr Green: The data�·5 suggest that cannabis use in early adolescence (ie, early c;mnabis use) is associated with an earHer onset of schizophrenia in a vulnerable population. Studies6-8 attest to gene-environment interactions. and a large Swedish conscript study9 showed that heavy marijuana use is associated with a higher rale of developing schizophrenia. The question that clinicians need answered is, \Vho is likciy to be at risk? Marijuana use may be more of a problem for some people than it would be for others.
WHAT IS THE RISK OF SCHIZOPHRENIA FOR MARIJUANA USERS?
Dr Kane: Determ ining the risk of schizoph renia is compl icated because, as Dr Green mentioned, it itlVolves potential gene-environment interactions.
IIJ CO�t.\lENTAR\·
• Recognize patients who may be vulnerable to psychotic disorders through their family history, social problems, and environmental factors.
• Discuss the risks of marijuana use with child and adolescent patients and their parents.
• Warn patients with psychotic disorders to avoid marijuana use. Dr Evins: In US high schools. I talk about tobacco use, which the students perceive as harmful. but that is nOt the case with marijuana use (Figure 2 ).so Dr Green: Although legalization is a complex sociopoliti cal question. when fOCUSing on the medical and psychi<ltric aspects. wt' all agree that there <lrt' serious risks with cannabis use in at least some :ldo!escents.
CONClUSION
Although the overall risk for people de\'e[oping schizo phrenia is small. a \'ulnerable minority mllst be warned that using mariju:lna during adolescence increases their risk for <Ie\'eloping schizophrenia. Clinicians should screen children and adolescents for marijuana lise ,md watch for signs of declining school performance or odd behavior that could indicate a predisposition for psychOSiS. With the potency increases in cannabis, patients must be aware that heavy. chronic cannabis use can cause serious effects on cognitive function, and patients with psychosis should a\'oid using cannabis because it can worsen their symptoms.
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II] COMMENTARY
Disc/osurl' of off-Itllul U�lJgt: Dr Evins has dctermined that, to the Ix-St of her knowledge. 110 im'estigational informal ion about pharmact"uli(al agems Ihat is olllside US Food and Drug Administr:l1ion-appro"cd labeling has becn prc$<'ntcd in this aClivil}'.
